Views

CrossRef citations to date

Altmetric

Omalizumab treatment in patients with severe chronic spontaneous urticaria: safety consideration from real-life experiences

Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab

Ester Del DucaDepartment of Dermatology, University of Rome “Tor Vergata”, Roma, ItalyCorrespondence[email protected]

Maria EspositoDepartment of Dermatology, University of Rome “Tor Vergata”, Roma, Italy

Stefania LechiancoleDepartment of Dermatology, University of Rome “Tor Vergata”, Roma, Italy

Alessandro GiuntaDepartment of Dermatology, University of Rome “Tor Vergata”, Roma, Italy

Luca BianchiDepartment of Dermatology, University of Rome “Tor Vergata”, Roma, Italy

Abstract

This article reports the rapid and complete remission of concomitant chronic spontaneous urticaria and atopic dermatitis, obtained in a woman of 32 years, after treatment with omalizumab, without adverse events.

Keywords:

Acknowledgement

Medical writing assistance of this paper was provided by Laura Brogelli, on behalf of Content Ed Net; this assistance was funded by Novartis.

Disclosure statement

The authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab

Information for

Open access

Opportunities

Help and information

Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab

Abstract

Acknowledgement

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature